CPT: Pharmacometrics & Systems Pharmacology (Mar 2020)

Machine Learning in Drug Discovery and Development Part 1: A Primer

  • Alan Talevi,
  • Juan Francisco Morales,
  • Gregory Hather,
  • Jagdeep T. Podichetty,
  • Sarah Kim,
  • Peter C. Bloomingdale,
  • Samuel Kim,
  • Jackson Burton,
  • Joshua D. Brown,
  • Almut G. Winterstein,
  • Stephan Schmidt,
  • Jensen Kael White,
  • Daniela J. Conrado

DOI
https://doi.org/10.1002/psp4.12491
Journal volume & issue
Vol. 9, no. 3
pp. 129 – 142

Abstract

Read online

Artificial intelligence, in particular machine learning (ML), has emerged as a key promising pillar to overcome the high failure rate in drug development. Here, we present a primer on the ML algorithms most commonly used in drug discovery and development. We also list possible data sources, describe good practices for ML model development and validation, and share a reproducible example. A companion article will summarize applications of ML in drug discovery, drug development, and postapproval phase.